Travere Therapeutics, Inc (TVTX)

(10% Negative) Travere Therapeutics, Inc (TVTX) Announces Delay in positioned Trials for successful commercial launch of FILSPARI in FSGS Due to Pandemic-Related Challenges, Patient Enrollment Issues, Regulatory Process, Manufacturing Considerations, Safety Review, Efficacy Assessment